Change in number of shares and votes in Episurf Medical

Following a resolution on the annual general meeting of Episurf Medical AB, 13,510 B-shares held by the company has been redeemed. As a consequence of the redemption, the number of B-shares and votes has decreased by 13,510. Following the decrease, the total number of shares amount to 15,949,804, of which 3,431,974 are A-shares with three votes each and 12,517,830 are B-shares with one vote each. Consequently, the total number of votes amounts to 22,813,752 after the decrease.

For more information, please contact:

Pål Ryfors, CFO, Episurf Medical

Tel: +46 709 62 36 69

Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

This information is information that Episurf Medical AB is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 13.00 CET on 29 July 2016.